Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Acitretin effectively treats severe hypertrophic lichen planus.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

2.5 mg/ml of triamcinolone acetonide is more effective for treating alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Valproate significantly improved headaches in two-thirds of patients.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Ondansetron can cause serious allergic reactions, so use it carefully.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.